Vivos Therapeutics (VVOS) Other Non-Current Assets (2019 - 2026)
Vivos Therapeutics (VVOS) reported Other Non-Current Assets of $254000.0 for Q1 2026, up 18.14% year-over-year from $215000.0 in Q1 2025, and up 11.4% on a QoQ basis from $228000.0 in Q4 2025.
Vivos Therapeutics (VVOS) has 8 years of Other Non-Current Assets data on file, last reported at $254000.0 in Q1 2026.
- Quarterly Other Non-Current Assets rose 18.14% year-over-year to $254000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $254000.0 (up 18.14% YoY) and the FY2025 annual result came in at $228000.0, up 5.56% from the prior year.
- Other Non-Current Assets improved to $254000.0 in Q1 2026 per VVOS's latest filing, from $228000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $374000.0 in Q4 2022 and bottomed at $211000.0 in Q3 2025.
- The 5-year median for Other Non-Current Assets is $307000.0 (2023), against an average of $290705.9.
- The widest annual swing landed in 2025, when Other Non-Current Assets sank 30.19%; it then gained 18.14% in 2026.
- Tracing VVOS's Other Non-Current Assets over 5 years: stood at $374000.0 in 2022, then fell by 17.91% to $307000.0 in 2023, then retreated by 29.64% to $216000.0 in 2024, then climbed by 5.56% to $228000.0 in 2025, then rose by 11.4% to $254000.0 in 2026.
- Per Business Quant, the three latest VVOS Other Non-Current Assets figures stand at $254000.0 (Q1 2026), $228000.0 (Q4 2025), and $211000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | 254,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | 228,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Jun 30, 2025 | 255,000.00 |
| Mar 31, 2025 | 215,000.00 |
| Dec 31, 2024 | 216,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Jun 30, 2024 | 276,000.00 |
| Mar 31, 2024 | 308,000.00 |
| Dec 31, 2023 | 307,000.00 |
| Sep 30, 2023 | 307,000.00 |
| Jun 30, 2023 | 308,000.00 |
| Mar 31, 2023 | 308,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 372,000.00 |
| Jun 30, 2022 | 373,000.00 |
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 356,000.00 |
| Sep 30, 2021 | 355,698.00 |
| Jun 30, 2021 | 374,648.00 |
| Mar 31, 2021 | 370,849.00 |
| Dec 31, 2020 | 309,000.00 |
| Dec 31, 2019 | 282,235.00 |